ID: ALA5190517

Max Phase: Preclinical

Molecular Formula: C24H35N7O2S

Molecular Weight: 485.66

Associated Items:

Representations

Canonical SMILES:  Nc1nc(NCCCCCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@@H]32)c2ccccc2n1

Standard InChI:  InChI=1S/C24H35N7O2S/c25-23-28-17-10-4-3-9-16(17)22(31-23)27-14-8-2-1-7-13-26-20(32)12-6-5-11-19-21-18(15-34-19)29-24(33)30-21/h3-4,9-10,18-19,21H,1-2,5-8,11-15H2,(H,26,32)(H2,29,30,33)(H3,25,27,28,31)/t18-,19-,21-/m0/s1

Standard InChI Key:  KGTQKLNGKSIFIW-ZJOUEHCJSA-N

Associated Targets(Human)

SQSTM1 Tbio Sequestosome-1 (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RNF168 Tbio E3 ubiquitin-protein ligase RNF168 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 485.66Molecular Weight (Monoisotopic): 485.2573AlogP: 3.03#Rotatable Bonds: 13
Polar Surface Area: 134.06Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.49CX Basic pKa: 7.18CX LogP: 2.37CX LogD: 2.26
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.22Np Likeness Score: -0.83

References

1. Wang FC, Peng B, Ren TT, Liu SP, Du JR, Chen ZH, Zhang TT, Gu X, Li M, Cao SL, Xu X..  (2022)  A 1,2,3-Triazole Derivative of Quinazoline Exhibits Antitumor Activity by Tethering RNF168 to SQSTM1/P62.,  65  (22.0): [PMID:36331508] [10.1021/acs.jmedchem.2c00432]

Source